To find new therapeutic targets for prostate cancer and improve early diagnosis and prognosis, we collected clinical trial data of patients and conducted a series of related experiments to reveal the clinical significance and biological role of DSCAM-AS1 in prostate cancer. This evidence concerns the gene DSCAM and Familial prostate cancer.